QuiVad

Home / Germany / Evotec SE

Evotec SE

Short position disclosed on October 21, 2026.

Follow

Evolution of the disclosed total

0%2.5%5%7.5%10%
Jan 2026Apr 2026Jul 2026Oct 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 11.77% on August 21, 2020. The shaded band matches the twelve months of the first chart.

February 27, 2013 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Highbridge Capital Management, LLC1.15%newOctober 12, 2026
Capital Fund Management SA0.90%newOctober 12, 2026
Whitebox Advisors LLC0.90%newOctober 12, 2026
Systematica Investments Limited0.81%newOctober 21, 2026
ActusRayPartners Limited0.77%newOctober 13, 2026
Y-Intercept (Hong Kong) Limited0.59%newOctober 15, 2026
Capital Ventures International0.57%newOctober 2, 2026
Vittoria and Partners LLP0.51%newSeptember 29, 2026
Algert Global LLC0.50%newSeptember 22, 2026
Millennium Capital Partners LLP0.50%newOctober 9, 2026

In the United States EVO (Nasdaq): 22,066 shares sold short on September 30, 2026.EVOTF (OTC): 2,803,455 shares sold short on September 30, 2026. FINRA names no fund.

On the other side: the funds that hold Evotec SE Titelia

Follow by RSS

Get the moves on Evotec SE by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

493 disclosures on record for this share.
DateFund% of capitalEnd of publication
April 25, 2018Systematica Investments Limited0.70%
April 24, 2018Worldquant, LLC0.48%
April 23, 2018Bluemountain Capital Management, LLC0.59%
April 19, 2018Systematica Investments Limited0.67%
April 18, 2018Systematica Investments Limited0.70%
April 9, 2018Worldquant, LLC0.51%
April 9, 2018Egerton Capital (UK) LLP0.47%
April 5, 2018Worldquant, LLC0.48%
April 4, 2018Wellington Management Company, LLP1.10%
March 26, 2018Lakewood Capital Management, LP0.82%
March 26, 2018AHL Partners LLP0.69%
March 26, 2018Worldquant, LLC0.59%
March 23, 2018Bluemountain Capital Management, LLC0.67%
March 22, 2018Worldquant, LLC0.60%
March 21, 2018Worldquant, LLC0.59%
March 16, 2018AHL Partners LLP0.79%
March 14, 2018Bluemountain Capital Management, LLC0.70%
March 13, 2018Oxford Asset Management0.51%
March 12, 2018AHL Partners LLP0.88%
March 12, 2018Worldquant, LLC0.67%
March 8, 2018Worldquant, LLC0.77%
March 8, 2018Bluemountain Capital Management, LLC0.67%
March 6, 2018Systematica Investments Limited0.69%
March 5, 2018Wellington Management Company, LLP1.02%
March 5, 2018Marshall Wace LLP0.44%
March 1, 2018AHL Partners LLP0.99%
March 1, 2018Bluemountain Capital Management, LLC0.78%
March 1, 2018Marshall Wace LLP0.55%
February 27, 2018Marshall Wace LLP0.68%
February 19, 2018AHL Partners LLP1.06%
February 19, 2018Worldquant, LLC0.89%
February 19, 2018Marshall Wace LLP0.79%
February 15, 2018AHL Partners LLP1.17%
February 14, 2018Bluemountain Capital Management, LLC0.81%
February 12, 2018AHL Partners LLP1.28%
February 8, 2018AHL Partners LLP1.36%
February 7, 2018Worldquant, LLC0.97%
February 7, 2018Marshall Wace LLP0.83%
February 6, 2018AHL Partners LLP1.44%
February 6, 2018Bluemountain Capital Management, LLC0.78%
February 1, 2018Worldquant, LLC1.09%
January 31, 2018Marshall Wace LLP0.94%
January 30, 2018Worldquant, LLC1.17%
January 29, 2018Bluemountain Capital Management, LLC0.86%
January 26, 2018AHL Partners LLP1.58%
January 26, 2018Worldquant, LLC1.28%
January 26, 2018Marshall Wace LLP0.80%
January 25, 2018Worldquant, LLC1.36%
January 24, 2018Worldquant, LLC1.45%
January 24, 2018Marshall Wace LLP0.73%

Download 493 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Germany

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Evotec SE, source Bundesanzeiger, data as at October 21, 2026, https://www.quivad.com/action/evotec-se?page=6